We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Aisling Capital Management
New York
$2.69M
QUSVM
2
Qiming U.S. Ventures Management
Washington
$2.25M
BI
3
BVF Inc
California
$2.19M
CAM
4
Cormorant Asset Management
Massachusetts
$1.85M
VP
5
venBio Partners
California
$1.77M
SB
6
Samsara BioCapital
California
$789K
TCM
7
Tang Capital Management
California
$456K +$487K +479,854 New
SCM
8
Sio Capital Management
New York
$342K
Vanguard Group
9
Vanguard Group
Pennsylvania
$317K +$288 +284 +0.1%
TCM
10
TCG Crossover Management
California
$274K -$271K -266,610 -48%
Renaissance Technologies
11
Renaissance Technologies
New York
$190K -$90.1K -88,757 -31%
KCM
12
Kennedy Capital Management
Missouri
$142K
BCM
13
Bridgeway Capital Management
Texas
$127K
Geode Capital Management
14
Geode Capital Management
Massachusetts
$85K -$288 -284 -0.3%
CC
15
Caxton Corporation
New Jersey
$64.8K +$27 +27 +0%
AC
16
Annandale Capital
Texas
$48K +$20.3K +20,000 +67%
BCM
17
BML Capital Management
Indiana
$38K +$40.6K +39,963 New
BlackRock
18
BlackRock
New York
$35.7K +$686 +676 +2%
State Street
19
State Street
Massachusetts
$17.5K
JP Morgan Chase
20
JP Morgan Chase
New York
$4K +$4.3K +4,240 New
UBS Group
21
UBS Group
Switzerland
$1.69K +$1.81K +1,782 New
TRCT
22
Tower Research Capital (TRC)
New York
$1K -$6.22K -6,125 -88%
SPIA
23
Steward Partners Investment Advisory
New York
$475
Barclays
24
Barclays
United Kingdom
$372
Morgan Stanley
25
Morgan Stanley
New York
$109